Axon Enterprise, Inc. Other Income (Expense) increased by 65.2% to $189.01M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 65.2%, from $114.40M to $189.01M.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$10.48M | -$10.48M | -$10.48M | -$10.48M | $71.59M | $71.59M | $71.59M | $71.59M | $114.40M | $189.01M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +783.4% | +0.0% | +0.0% | +0.0% | +59.8% | +65.2% |
| YoY Change | — | — | — | — | +783.4% | +783.4% | +783.4% | +783.4% | +59.8% | +65.2% |